# GO_molecular_function_0069

[All 1,736 questions](../README.md) · [Method and limits](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_molecular_function`  
**Author expected answer:** **B** — FMN binding

| Expected-answer support | Reasoning versus lookup | Review status |
|---|---|---|
| supported | lookup-dependent | format-valid AI review |

These labels are Luna’s original judgments. Source support and reasoning from the original input are separate questions. The benchmark key and original score are unchanged.

## Complete original question

The sequence and choices below are the complete original user message, in their original order.

```text
[Protein Sequence]
MDNSSRLFSPLRLGKCQLRHRVAMSPLTRFRADDLSVQMPFAKEYYAQRASVPGTFLVSEATSISRESVGFSNVPGIWNAEQVRAWKEIADDVHCKGSFLFLQLWATGRSATPERLQSGDFDFASSSAVPMEPGGAVPRELTEEDIHDLIARFAEAARRAIDAGMDGIELHAANGYLIDQFTQASCNQRTDRWGGSIENRARFAIEVTRSVVAAVGADRVGVKLSPWGKIQGMGTMQDLVPQFQYLVSELRDMGLAYLRLSNSRWIDGVPQEEEDNSIYVHTWGASRPVLLEGGYDPISAQKEADIRFNGYDAVIAFGRFFISNPDLPFRIKAGVDLQKYNRDTFYTPISEKGYIDYPFSTAFLEEHSSKASLKL

[Multiple Choices]
A. peptide binding
B. FMN binding
C. amidophosphoribosyltransferase activity
D. flavin adenine dinucleotide binding
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Molecular Function Prediction, which is to predict the fundamental activity of a protein at the molecular level, as defined by the Gene Ontology (GO) 'Molecular Function' branch. This describes the elemental tasks a protein performs, such as catalysis, transport, or binding to specific molecules. Based on the protein's amino acid sequence, you are to select the option that best describes its primary molecular function.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Luna’s full visible review

### Expected-answer support: supported

> The exact sequence matches the FrzD entry, whose historical and current UniProt annotations include FMN binding. That GO annotation is computationally assigned by InterPro (IEA), not direct experimental evidence of FMN binding; separate cited evidence supports FrzD's flavin-dependent reductase role.

Cited evidence: [C1](#evidence-c1), [C7](#evidence-c7), [H5](#evidence-h5), [H3](#evidence-h3), [H4](#evidence-h4).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The options make flavin-cofactor binding a relevant distinction, but the sequence alone provides no sufficiently concrete cue here to choose FMN over FAD binding.

**Missing item-specific fact**

> The protein's identification as FrzD, or an equivalent family/cofactor annotation establishing FMN rather than FAD specificity, is absent from the input.

**Reason**

> The expected choice is supported by sequence-matched database evidence, but that protein-specific annotation was not supplied. Recognizing the exact sequence or recalling its entry would be lookup or memorization, not reasoning from the presented information.

### Question ambiguity

**Multiple defensible options named by Luna:** none.

> The listed functions are distinct; the issue is that the input does not provide a reliable basis to resolve the FMN-versus-FAD distinction, rather than the wording making multiple functions simultaneously correct.

### Important caveats

- The FMN-binding GO annotation is IEA:InterPro and should not be represented as a direct experimental binding measurement.
- The exact author annotation snapshot is unknown, although a historical sequence-matched entry already contains the FMN-binding annotation.

<details>
<summary>Saved visible review as JSON</summary>

```json
{
  "case_id": "GO_molecular_function_0069",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the FrzD entry, whose historical and current UniProt annotations include FMN binding. That GO annotation is computationally assigned by InterPro (IEA), not direct experimental evidence of FMN binding; separate cited evidence supports FrzD's flavin-dependent reductase role.",
    "evidence_ids": [
      "C1",
      "C7",
      "H5",
      "H3",
      "H4"
    ]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The options make flavin-cofactor binding a relevant distinction, but the sequence alone provides no sufficiently concrete cue here to choose FMN over FAD binding.",
    "missing_item_specific_fact": "The protein's identification as FrzD, or an equivalent family/cofactor annotation establishing FMN rather than FAD specificity, is absent from the input.",
    "reason": "The expected choice is supported by sequence-matched database evidence, but that protein-specific annotation was not supplied. Recognizing the exact sequence or recalling its entry would be lookup or memorization, not reasoning from the presented information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The listed functions are distinct; the issue is that the input does not provide a reliable basis to resolve the FMN-versus-FAD distinction, rather than the wording making multiple functions simultaneously correct."
  },
  "important_caveats": [
    "The FMN-binding GO annotation is IEA:InterPro and should not be represented as a direct experimental binding measurement.",
    "The exact author annotation snapshot is unknown, although a historical sequence-matched entry already contains the FMN-binding annotation."
  ]
}
```

</details>

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**This source material was supplied only to the reviewer. It was absent from the original evaluated question.** An exact-sequence database match can support a key without establishing that the question can be answered by reasoning from its original input.

**Accession:** `A0A7T8F1M9`; identity was recovered from dataset image-path metadata and was absent from the evaluated model input.  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; selected entry version 11. The exact author source snapshot remains unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M9.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.159757+00:00.  

```json
"A0A7T8F1M9"
```

Source SHA-256: `c38628844912ac2c4aa489f4067b5327e7aad3e6384ffb308551b50b6f0b30ee`.

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1M9.json)  
**Locator:** `/uniProtKBCrossReferences/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:51.159757+00:00.  

```json
{"database":"GO","id":"GO:0010181","properties":[{"key":"GoTerm","value":"F:FMN binding"},{"key":"GoEvidenceType","value":"IEA:InterPro"}]}
```

Source SHA-256: `c38628844912ac2c4aa489f4067b5327e7aad3e6384ffb308551b50b6f0b30ee`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M9?format=txt&versions=11)  
**Locator:** `lines 25-55`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-01T06:27:35.126419+00:00.  

```text
CC   -!- FUNCTION: Aldehyde reductase; part of the gene cluster that mediates
CC       the biosynthesis of the alkaloid (-)-FR901483, a potent
CC       immunosuppressant that shows efficacy in animal models and a probable
CC       inhibitor of purine nucleotide biosynthesis by targeting
CC       phosphoribosylpyrophosphate amidotransferase (PPAT) (PubMed:33372776).
CC       Within the pathway, FrzD reduces the dienone portion of the pathway
CC       intermediates to cyclohexanone (PubMed:33372776). The biosynthesis of
CC       (-)-FR901483 starts with the condensation of two L-tyrosines to yield
CC       (S,S)-dityrosyl-piperazine. This process occurs in 3 steps with the
CC       non-canonical nonribosomal peptide synthetase FrzA catalyzing the
CC       reduction of L-tyrosine into L-tyrosinal, the spontaneous condensation
CC       of 2 L-tyrosinal units, and the subsequent reduction by the NmrA-like
CC       family domain-containing oxidoreductase FrzB. The cytochrome P450
CC       monooxygenase FrzC then performs coupling between N10 and C1' to morph
CC       the piperazine into a 1,4-diazabicyclo[3.2.1]octane spiro-fused to a
CC       2,5-cyclohexadienone. The dienone portion is further reduced to
CC       cyclohexanone by the flavin-dependent reductase FrzD. The
CC       methyltranserases (MTs) FrzE and FrzF are then involved in the
CC       methylation at the C10' amine and the C4 phenolic oxygen, respectively.
CC       The order of the two MTs appear to be interchangeable. Cleavage of the
CC       C9-N10' bond by the dioxygenase FrzG then leads to formation of a
CC       conjugated iminium. In addition to the oxidation of C9, an additional
CC       dehydrogenation between C7 and C8 can occur to give a likely shunt
CC       product. The next biosynthetic step is the intramolecular aldol
CC       condensation catalyzed by the newly identified aldolase FrzH to yield
CC       an aza-tricyclic product with the formation of a C9-C3' bond
CC       (PubMed:33372776). The short-chain dehydrogenase/reductase FrzI then
CC       produces dephospho-(-)-FR901483 that is phosphorylated at C4'-OH into
CC       (-)-FR901483 by the phosphotransferase FrzJ (PubMed:33372776). The only
CC       unassigned enzyme in the cluster is the second cytochrome P450
CC       monooxygenase FrzL (PubMed:33372776). {ECO:0000269|PubMed:33372776}.
```

Source SHA-256: `fd48d108f45a92963462c2f0a750dcecfac5cc36c43941b4ca5d31b971333839`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M9?format=txt&versions=11)  
**Locator:** `lines 56-65`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-01T06:27:35.126419+00:00.  

```text
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexane]-2',5'-dien-4'-one +
CC         2 NADPH + 2 H(+) = (1S,4S)-4-[(4-hydroxyphenyl)methyl]-2,5-
CC         diazaspiro[bicyclo[3.2.1]octane-6,1'-cyclohexan]-4'-one + 2 NADP(+);
CC         Xref=Rhea:RHEA:83583, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:233174, ChEBI:CHEBI:233175;
CC         Evidence={ECO:0000269|PubMed:33372776};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:83584;
CC         Evidence={ECO:0000269|PubMed:33372776};
```

Source SHA-256: `fd48d108f45a92963462c2f0a750dcecfac5cc36c43941b4ca5d31b971333839`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1M9?format=txt&versions=11)  
**Locator:** `lines 80-80`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 11 / 1.  
**Retrieved:** 2026-11-01T06:27:35.126419+00:00.  

```text
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
```

Source SHA-256: `fd48d108f45a92963462c2f0a750dcecfac5cc36c43941b4ca5d31b971333839`.

---

Question and key: [LiveProteinBench source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_molecular_function.json) (zero-based source row 69). Benchmark content © 2026 LiveProteinBench contributors, [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). Cited UniProt / Gene Ontology excerpts retain their own attribution; see [source credits](../THIRD_PARTY_NOTICES.md).
